
    
      Core part: randomized, double-blind, placebo-controlled study - 8-week treatment Extension
      part for participants completing the core part: Open label non-controlled study - 16-week
      treatment

      Each patient's participation in the study will be approximately 13 or 33 weeks depending on
      their participation in the extension part: up to 2 weeks of screening, 8 weeks of treatment
      in the core part, 1 to 30 days wash-out between core part and extension part , 16 weeks of
      treatment in the extension part and 3 weeks of follow up.
    
  